Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Adipocyte
- Vol. 9 (1) , 576-586
Abstract
Regular exercise is the first line of therapy for treating obesity-mediated metabolic disorders, including insulin resistance. It has been reported that developmental endothelial locus-1 (DEL-1) enhances macrophage efferocytosis, resulting in inflammation clearance as well as improves insulin resistance in skeletal muscle. However, the relationship between exercise and DEL-1, and the effects of DEL-1 on insulin signalling in adipocytes have not been fully elucidated to date. Protein expression levels were determined by Western blot analysis. Cells were transfected with small interfering (si) RNA to suppress gene expression. Lipid accumulation levels were detected using Oil red-O staining. Proinflammatory cytokine secretion levels were measured using ELISA. DEL-1 expression levels were induced in the skeletal muscle of people who exercised using microarray analysis. Recombinant DEL-1 augmented AMP-activated protein kinase (AMPK) phosphorylation and haem oxygenase (HO)-1 expression to alleviating inflammation and impairment of insulin signalling in 3T3-L1 adipocytes treated with palmitate. siRNA of AMPK or HO-1 also mitigated the effects of DEL-1 on inflammation and insulin resistance. DEL-1 ameliorates inflammation and insulin resistance in differentiated 3T3-L1 cells via AMPK/HO-1 signalling, suggesting that DEL-1 may be the exercise-mediated therapeutic target for treating insulin resistance and type 2 diabetes. Graphical abstractKeywords
Funding Information
- National Research Foundation of Korea (2019R1A2C4070189)
- Chung-Ang University
This publication has 53 references indexed in Scilit:
- State of the art paper Biochemistry of adipose tissue: an endocrine organArchives of Medical Science, 2013
- The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone lossNature Immunology, 2012
- Chronic Inflammation in Obesity and the Metabolic SyndromeMediators of Inflammation, 2010
- Overexpression of HO-1 Protects against TNF-α-Mediated Airway Inflammation by Down-Regulation of TNFR1-Dependent Oxidative StressThe American Journal of Pathology, 2009
- Immunoregulatory effects of HO-1: how does it work?Current Opinion in Pharmacology, 2009
- Novel aspects in the regulation of the leukocyte adhesion cascadeThrombosis and Haemostasis, 2009
- Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell RecruitmentScience, 2008
- Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006
- THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger GasesAnnual Review of Pharmacology and Toxicology, 1997